Boston Scientific Corporation
Marktkapitalisatie
$73.1B
Wereldwijde rang
#217
Recordhoogte
$141.7B
2025-12-31
Totale groei
+0%
sinds 2026
Market Cap Context
- Larger than 41% of the 367 companies we track (globally).
- Equivalent to 0.2% of United States's GDP (2025 data).
- Just above: #216 O'Reilly Automotive, Inc. ($73.4B)
- Just below: #218 Colgate-Palmolive Company ($72.9B)
- Best year: 1995 (+183%). Worst year: 2026 (-48%).
Boston Scientific Corporation Financial Breakdown (FY 2025)
Source: Yahoo Finance โ BSX annual filings (2025) โ$20.1B revenue ยท $4.0B operating income ยท $2.9B net income
- โOperating margin: 19.8% on $20.1B in revenue.
- โR&D is 10.2% of revenue ($2.1B).
- โNet income margin: 14.4% โ $2.9B in profit.
- โFree cash flow: $3.4B (17.0% of revenue).
Cost / Operating Expenses
Total operating expenses $16.1B
Total
$15.2B
Capital Expenditures
$1.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$3.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Over Boston Scientific Corporation
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Marktkapitalisatiegeschiedenis van Boston Scientific Corporation (2026โ2026)
Boston Scientific Corporation vs Sector Peers by Market Cap
Boston Scientific Corporation vergelijken
Ranggeschiedenis
| Jaar | Marktkapitalisatie | Rang | Verandering op jaarbasis |
|---|---|---|---|
| 2026 | $73.1B | #217(โ105) | -48.4% |
| 2025 | $141.7B | #112(โ14) | +6.8% |
| 2024 | $132.8B | #98(โ34) | +54.5% |
| 2023 | $85.9B | #132(โ1) | +24.9% |
| 2022 | $68.8B | #131(โ22) | +8.9% |
| 2021 | $63.1B | #153(โ12) | +18.2% |
| 2020 | $53.4B | #165(โ63) | -20.5% |
| 2019 | $67.2B | #102(โ8) | +28.0% |
| 2018 | $52.5B | #94(โ66) | +42.6% |
| 2017 | $36.8B | #160(โ18) | +14.6% |
| 2016 | $32.1B | #142(โ6) | +17.3% |
| 2015 | $27.4B | #148(โ46) | +39.2% |
| 2014 | $19.7B | #194(โ8) | +10.2% |
| 2013 | $17.9B | #186(โ36) | +109.8% |
| 2012 | $8.5B | #222(โ15) | +7.3% |
| 2011 | $7.9B | #207(โ27) | -29.5% |
| 2010 | $11.3B | #180(โ37) | -15.9% |
| 2009 | $13.4B | #143(โ23) | +16.3% |
| 2008 | $11.5B | #120(โ8) | -33.4% |
| 2007 | $17.3B | #128(โ59) | -32.3% |
| 2006 | $25.5B | #69(โ28) | -29.8% |
| 2005 | $36.4B | #41(โ25) | -31.1% |
| 2004 | $52.8B | #16(โ1) | -3.3% |
| 2003 | $54.6B | #15(โ11) | +72.9% |
| 2002 | $31.6B | #26(โ35) | +76.3% |
| 2001 | $17.9B | #61(โ32) | +76.2% |
| 2000 | $10.2B | #93(โ34) | -37.4% |
| 1999 | $16.3B | #59(โ18) | -18.4% |
| 1998 | $19.9B | #41(โ3) | +16.9% |
| 1997 | $17.0B | #38(โ17) | -23.5% |
| 1996 | $22.3B | #21(โ1) | +21.8% |
| 1995 | $18.3B | #20(โ12) | +183.5% |
| 1994 | $6.5B | #32 |
Andere bedrijven in de sector Gezondheidszorg
Veelgestelde vragen
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation (BSX) has a market capitalization of $73.1B, making it the #217 largest company in the world by market cap.
What was Boston Scientific Corporation's highest market cap?
Boston Scientific Corporation's all-time high market cap was $141.7B, reached in 2025-12-31. Its highest rank was #112 in 2025.
What sector is Boston Scientific Corporation in?
Boston Scientific Corporation is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has Boston Scientific Corporation's market cap changed over time?
Boston Scientific Corporation has been tracked since 2026. Its market cap has grown by 0% from $73.1B in 2026 to $73.1B today.